Article info
Heart failure and cardiomyopathies
Original article
Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure
- Correspondence to Dr Yung-Tai Chen, Department of Nephrology, Taipei City Hospital Heping Fuyou Branch, Taipei 112, Taiwan; ytchen0117{at}gmail.com Dr Chia-Jen Shih, Deran Clinic, Yilan 260, Taiwan; drcjshih{at}gmail.com
Citation
Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure
Publication history
- Received April 1, 2016
- Revised August 8, 2016
- Accepted August 15, 2016
- First published September 19, 2016.
Online issue publication
February 27, 2017
Article Versions
- Previous version (19 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/